A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
Initiated second-line treatment at least 3 months prior to the date of data collection, with either :
* Afatinib
* Any chemotherapy
Age ≥ 18 years
You may not be if
Received pembrolizumab in combination with platinum-based chemotherapy as part of an interventional clinical trial
Clareo Health | A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
